AMN vs. CHE, RCM, CRVL, AMED, MD, CCRN, LH, DGX, DVA, and RHI
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include Chemed (CHE), R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), and Robert Half (RHI).
Chemed (NYSE:CHE) and AMN Healthcare Services (NYSE:AMN) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking and earnings.
In the previous week, Chemed and Chemed both had 7 articles in the media. AMN Healthcare Services' average media sentiment score of 0.92 beat Chemed's score of 0.54 indicating that Chemed is being referred to more favorably in the media.
95.9% of Chemed shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 3.3% of Chemed shares are held by company insiders. Comparatively, 0.9% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Chemed has a net margin of 12.36% compared to Chemed's net margin of 4.13%. Chemed's return on equity of 31.39% beat AMN Healthcare Services' return on equity.
AMN Healthcare Services received 108 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 68.87% of users gave AMN Healthcare Services an outperform vote while only 63.46% of users gave Chemed an outperform vote.
Chemed pays an annual dividend of $1.60 per share and has a dividend yield of 0.3%. AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 2.1%. Chemed pays out 8.6% of its earnings in the form of a dividend. AMN Healthcare Services pays out 32.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 15 consecutive years.
Chemed has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.
Chemed presently has a consensus target price of $673.50, indicating a potential upside of 21.49%. AMN Healthcare Services has a consensus target price of $75.57, indicating a potential upside of 35.09%. Given Chemed's higher probable upside, analysts clearly believe AMN Healthcare Services is more favorable than Chemed.
Chemed has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, AMN Healthcare Services has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500.
Summary
Chemed beats AMN Healthcare Services on 12 of the 20 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
